Thrombopoietin materials can be administered with substantial therapeutic effect in a single or low-multiple daily administration. Reversal of thrombocytopenia is achieved by administering to a patient having or in need of such treatment a single or low-multiple daily dose of a therapeutically effective amount of a thrombopoietin.
申请公布号
CA2288964(A1)
申请公布日期
1998.11.26
申请号
CA19982288964
申请日期
1998.05.21
申请人
GENENTECH, INC.
发明人
POWELL, MICHAEL F.;SWEENEY, THERESA D.;EATON, DAN L.;JONES, DENNIE V.;JONES, ANDREW J.S.;COHEN, ROBERT L.;WAGEMAKER, GERARD;THOMAS, G. ROGER